Koyfin Home > Directory > Health Care > Adamas Pharma > EV / Sales (ntm)

Adamas Pharma EV / Sales (ntm) Chart (ADMS)

Adamas Pharma annual/quarterly EV / Sales (ntm) from 2014 to 2020.
  • Adamas Pharma EV / Sales (ntm) for the quarter ending October 10, 2020 was 1.48 a -4.51% decrease of -0.07 year over year
  • Adamas Pharma EV / Sales (ntm) for the last 12 months ending October 10, 2020 was 1.48 a -4.51% decrease of -0.07 year over year
  • Adamas Pharma Annual EV / Sales (ntm) for 2020 was 1.48 a -0.43% decrease of -0.01 from 2019
  • Adamas Pharma Annual EV / Sales (ntm) for 2020 was 1.49 a -1.28% decrease of -0.02 from 2019
  • Adamas Pharma Annual EV / Sales (ntm) for 2020 was 1.51 a -2.75% decrease of -0.04 from 2019
Other Valuation Metrics:
  • Adamas Pharma Market Cap for the quarter ending March 03, 2018 was $641m a 38.96% increase of 250m year over year
  • Adamas Pharma Price / Book for the quarter ending March 03, 2018 was 8.43 a 61.32% increase of 5.17 year over year
  • Adamas Pharma Enterprise Value for the quarter ending March 03, 2018 was $570m a 51.05% increase of 291m year over year
View Chart On Koyfin

Quarterly ADMS EV / Sales (ntm) Data

10/20201.48
10/20201.49
10/20201.51
10/20201.55
10/20201.62
10/20201.68
10/20201.80
10/20201.85
10/20201.91
10/20201.97

Annual ADMS EV / Sales (ntm) Data

20201.48
20201.49
20201.51
20201.55
20201.62
20201.68
20201.80
20201.85
20201.91
20201.97